Program in Detail

Empowering excellence: advancing the quality and safety of gynaecological cancer care in Queensland

Chair: Rhett Morton

7:00 AM Rhett Morton

Navigating the pathways: Patterns of care for all women with gynaecological cancer in Queensland  abs# 1

7:15 AM Tamara Butler

Ensuring equity: Monitoring health outcomes for Queensland First Nations women with cervical and endometrial cancer abs# 2

7:30 AM Penny Mackenzie

Trends in the utilisation of brachytherapy in cervical cancer in Queensland: How do we compare? abs# 3

7:45 AM Shaun McGrath

Increased endometrial cancer rates: The link between obesity and endometrial cancer risk abs# 4

Session sponsored by

Innovations in Implementing Nutrition and Exercise Evidence to Enhance Cancer Care and Outcomes

Co-Chair: Jenelle Loeliger

Co-Chair: David Mizrahi

This session will include interactive Q&A with all speakers.

This breakfast session is sponsored by COSA, and delivered by the COSA Nutrition and Exercise and Cancer Groups

Best of the Best Posters – Epidemiology

Chair: Ashley Hopkins

Discussant: Rebecca Venchiarutti

7:15 AM Maria Aslam

Prevalence of Australians exposed to potentially cardiotoxic cancer medicines: A population-based cohort study abs# 301

7:20 AM Vicki Durston

Making metastatic breast cancer count: Barriers, enablers and key recommendations identified through expert interviews and a national roundtable abs# 304

7:25 AM Lucy Gately

Linking data from a brain cancer clinical registry (BRAIN) with the state-based registry of Births Deaths Marriages: Improving the quality of clinical registry survival data abs# 305

7:30 AM Huah Shin Ng

Patterns of mental health service utilisation in people with cancer compared with people without cancer: The Australian National Study of Mental Health and Wellbeing analysis abs# 312

7:35 AM Suzanne Poulgrain

Patterns of treatment and survival outcomes for people diagnosed with glioblastoma: A population-based study in Queensland abs# 314

7:40 AM Robert Power

Modifiable risk factors for cancer among people with Lynch syndrome: An international, cross-sectional survey abs# 315

7:45 AM Euan Walpole

Benchmarking statewide cancer data: A comparison of breast and gynaecological cancer care indicators between Victoria and Queensland abs# 316

Session sponsored by 

Best of the Best Posters – Clinical Research & Supportive Care

Chair: Laura Kirsten

Discussant: Desmond Yip

7:15 AM Morgan Farley

Myokine response to high intensity interval exercise and relationships with body composition and cardiorespiratory fitness in cancer survivors abs# 198

7:20 AM Wing Kwan Winky Lo

Correlation of Quantitative Emphysema and Lung Nodules on Low-dose CT (LDCT) in the Sydney Cohort of International Lung Screening Trial (ILST) abs# 214

7:25 AM Claire Munsie

‘My Life Now is… ’; Benefits of group-based exercise in adolescent and young adult cancer survivors in their own words. abs# 479

7:30 AM Andrew Murnane

Fitness, body composition and HRQoL in long-term survivors of adolescent and young adult (AYA) cancers. abs# 480

7:35 AM Prabhakar Ramachandran

A multi-institutional study on long-term incidence of contralateral second breast cancer following breast cancer radiation therapy – Preliminary results. abs# 263

7:40 AM Helena Rodi

What do Australian oncology health professionals know and practice regarding advance care planning? abs# 295

7:45 AM Ursula Sansom-Daly

Do young people who survive cancer, identify as ‘survivors’? Prevalence and predictors of cancer-related identities among adolescents and young adults following cancer abs# 483

Session sponsored by 

 

Opening Ceremony Plenary 1

Chairs: Dion Forstner & Belinda Yeo

Welcome by COSA President

Welcome to Country

Official opening by Her Excellency Professor the Honourable Margaret Gardner AC Governor of Victoria

50 years of cancer care: the past, present and future

9:00 AM Michael Friedlander

Lessons learned over 50 years – reflections on the progress in improving outcomes of Australians with ovarian cancer and the opportunities and challenges ahead abs# 5

9:20 AM Meinir Krishnasamy

Nurse-led interventions in breast and gynaecological cancers: Where to from here? abs# 6

9:40 AM Bruce Mann

Diagnosis and treatment of very early breast cancer abs# 7

10:00 AM Darren Brenner

How can we improve future cancer outcomes with big data and analytics? abs# 8

10:20 AM Panel discussion

Session sponsored by 

 

Tea break sponsored by 

 

Fertility – before, during and after cancer

Chair: Lesley Stafford

11:00 AM Kate Stern

Fertility preservation for cancer patients: Light at the end of the tunnel abs# 9

11:15 AM Michelle Peate

Supporting informed decision making in the fertility preservation process including work on fertility decision aids and the FORECAST study abs# 10

11:30 AM Christobel Saunders

POSITIVE news for women after breast cancer  abs# 11

11:45 AM Wanda Cui

Ovarian toxicity assessment in cancer clinical trials – Where are we now? abs# 12

12:00 PM Panel discussion

Session sponsored by 

Using a multidisciplinary approach to customise models of cancer care

Chair: Ray Chan

11:00 AM Faye Coe

Pharmacist led prescribing clinics: The service framework abs# 13

11:20 AM Jordan Casey

Culturally safe multidisciplinary care abs# 14

11:40 AM Michael Jefford

Sharing is caring: Models of shared care abs# 15

12:00 PM Vivienne Interrigi

Surviving Cancer with a Community around Us

12:20 PM Panel discussion

Multidisciplinary and multistrategy approach to reducing risk of CVD for cancer patients and survivors

Chair: Bogda Koczwara

11:00 AM Ben Felmingham

Designing and implementing a pediatric cardio-oncology clinic using Delphi consensus driven guidelines as a model to guide care abs# 17

11:15 AM Abbey Diaz

Development of patient resources on cardiovascular health for Aboriginal and Torres Strait Islander people living with and beyond cancer abs# 18

11:30 AM Erin Howden

The role of exercise to mitigate cardiovascular disease in cancer survivors abs# 19

11:45 AM Alexandra Murphy

Cardio-oncology: Prevention is better than cure abs# 20

12:00 PM Panel discussion

Best of the Best Oral Presentations – Epidemiology

Chair: Brigid Lynch

Discussant: Darren Brenner

11:00 AM Bryan Chan

Sino-nasal Undifferentiated Carcinoma (SNUC) in Queensland: A state-wide review from 1982 to 2021 abs# 21

11:15 AM Katherine Faulks

Towards an estimate of the prevalence of lymphoedema in Australia abs# 22

11:30 AM Visalini Nair-Shalliker

Can metformin reduce the risk of aggressive prostate cancer? Results from the 45 and Up Study. abs# 23

11:45 AM Andrea Smith

Metastatic breast cancer (mBC) prevalence in New South Wales (NSW) estimated from two population-based breast cancer cohorts: A health record linkage study, 2001–2016 abs# 24

12:00 PM Jin Quan Eugene Tan

Patterns of cardiovascular medication utilisation in people with cancer: The Australian National Health Survey linked data analysis abs# 25

12:15 PM Carla Thamm

Patterns of care and health service costs for adolescent and young adults cancer survivors in Queensland abs# 26

Best of the Best Oral Presentations – Breast Cancer

Chair: Fran Boyle

Discussant: Etienne Brain

11:00 AM Kelly D'cunha

Modifiable lifestyle behaviors and biomarkers of inflammation and insulin resistance in female breast cancer survivors participating in a weight loss trial. abs# 27

11:15 AM Norah Finn

Alignment with the early detection phase of the Optimal Care Pathways is associated with improved outcomes for women with breast cancer abs# 28

11:30 AM Caitlin I Fox-Harding

High versus low load resistance exercise for breast cancer-related lymphoedema: A randomised controlled trial abs# 29

11:45 AM Yada Kanjanapan

Real world analysis of breast cancer patients qualifying for adjuvant CDK4/6 inhibitors abs# 30

12:00 PM Antonia Pearson

Genitourinary symptoms in women with breast cancer: Patients’ attitudes and experiences abs# 31

12:15 PM Kate Webber

The impact of real-time Patient Reported Outcome Measures (PROMs) on Emergency Department presentations in people with breast cancer abs# 32

Lunch sponsored by 

 

Answering those age old questions in Geriatric Oncology

1:30 PM Etienne Brain

Research in demographic transition for breast cancer (thoughts for international and academic collaboration) abs# 33

1:50 PM Heather Lane

Geriatric oncology: The role of the Geriatrician abs# 34

2:05 PM Michael Krasovitsky

Caring for older individuals with cancer: Musings of a medical oncologist  abs# 35

2:20 PM Polly Dufton

The role of nursing and allied health in caring for older adults with cancer abs# 36

2:35 PM Panel discussion

Session sponsored by 

 

Cancer-related lymphoedema: prevention through to management

Chair: Sandi Hayes

4:00 PM Melanie Plinsinga

How big of a problem is lymphoedema? abs# 37

4:17 PM Louise Koelmeyer

The quest for preventing lymphoedema abs# 38

4:34 PM Hildegard Reul-Hirche

Reducing the impact of lymphoedema: Conservative management through to surgical approaches abs# 39

4:51 PM Kira Bloomquist

Impact of exercise and weight management on cancer-related lymphoedema abs# 40

5:08 PM Debbie Geyer

Dispelling myths in lymphoedema management abs# 41

5:25 PM Panel discussion

Medicine Matters

Chair: Chi Hao La

4:00 PM  Faye Coe

Average duration of prior treatment lines predicts clinical benefit to eribulin chemotherapy to patients with metastatic breast cancer abs# 42

4:20 PM Gail Rowan

New and emerging antibody drug conjugates in breast cancer abs# 43

4:40 PM Peter Savas

Harnessing the immune system in breast cancer abs# 44

5:00 PM Olivia Smibert

Medicines and the microbiome abs# 45

Cervical cancer elimination strategy: an Australian success story inspiring global action

Chair: Marion Saville

4:00 PM Karen Canfell

Overview of the Australian and global strategies abs# 46

4:15 PM Julia Brotherton

Implementation strategies for improving uptake of vaccination and screening? abs# 47

4:30 PM Lisa Whop

Achieving cervical cancer elimination in Aboriginal and Torres Strait Islander communities abs# 48

4:45 PM Farhana Sultana

HPV cervical screening in Australia: self-collection uptake and follow-up in the program abs# 49

5:00 PM Panel discussion

Best of the Best Oral Presentations – Supportive Care

Chair: Belinda Steer

Discussant: Michael Jefford

4:00 PM Louisa Gordon

Cost-utility analysis of a telehealth psychological support intervention for people with primary brain tumour: Telehealth making sense of brain tumour abs# 50

4:15 PM Lauren Ha

Striving towards better assessment of physical activity and sedentary behaviour: A novel cluster analysis approach using wrist accelerometry in childhood cancer survivors abs# 51

4:30 PM Bogda Koczwara

Pain and its interference with daily living in relation to cancer: A comparative population-based study of 16,053 cancer survivors and 106,345 people without cancer abs# 52

4:45 PM Claire Munsie

Potential impact of exercise upon symptom burden in adolescents and young adults undergoing cancer treatment. abs# 53

5:00 PM Eli Ristevski

Financial toxicity among rural cancer survivors in Gippsland, Victoria, Australia abs# 54

5:15 PM Eva Yuen

Does caregiver and cancer patient health literacy, social support and connectedness impact caregiver psychological morbidity? abs# 55

Best of the Best Oral Presentations – Health Services I

Chair: Wei-Sam Lam

Discussant: Kim Hobbs

4:00 PM Jennifer Cohen

A parent-led program to promote healthy eating habits in children living beyond cancer: A pilot randomised-controlled trial. abs# 56

4:15 PM Prue Cormie

Exercise conversations: A mixed methods study explaining what health professionals require to embed exercise recommendations into routine cancer care abs# 57

4:30 PM  Suzanne Grant

Training healthcare interpreters about cancer clinical trials abs# 58

4:45 PM Ella Sexton and Hannah Ray

Implementation of a prehabilitation model of care using co-designed resources for head and neck cancer patients undergoing radiotherapy abs# 59

5:00 PM Shalini Vinod

Lung cancer (internet-based) Delphi (LuCiD): A modified eDelphi consensus to establish Australasian thoracic oncology clinical quality indicators abs# 60

5:15 PM Haitham Tuffaha

Consensus recommendations for genetic testing in prostate cancer: A Delphi study abs# 61

COSA Advanced Trainee Dinner: The complete guide on how to treat high risk early breast cancer - getting the multidisciplinary team's perspective from our experts

Chair: Belinda Yeo

This dinner is especially for our trainees in any specialty of breast cancer management. We will hear the important surgical, plastics, radiation and medical oncology perspectives of how to treat high risk early breast cancer. The challenges for the patient and the clinician in working out what treatment to give, in what order and what imaging and pathological information is required to make these informed decisions.

We look forward to a fun night to meet your colleagues in related disciplines of breast cancer care!

This meeting is financially sponsored by Novartis. The content and agenda have been developed independently by COSA and medical experts.

Cancer Pharmacists Dinner – Moving towards Pharmacist Prescribing: Meeting the needs of our patients

Co-Chair: Marissa Ryan

Co-Chair: Kimberley-Ann Kerr

Pharmacist prescribing in cancer – are we getting close?

Pharmacists are already actively providing excellent care to cancer patients during pre-admission, treatment and discharge or transition planning. The role of a clinical pharmacist has evolved, pharmacists are providing valuable advice to the medical team after reviewing medication related issues of the patients. While there have been proposals and trial initiatives in the community setting, pharmacist prescribing in Australia is currently very limited. In contrast, pharmacists have been prescribing in the UK since 2003.

How did they get there? What can we learn from our colleagues from UK? What are some of the challenges the pharmacist prescribers faced?

In this symposium, we will have discussion of the UK model, how it works and the advanced pharmacist practice happening in Australia, including Partnered Pharmacist Medication Charting (PPMC).

The PPMC Model has been tested and implemented in Victoria in both general medicine and more recently in the oncology setting. Under the PPMC model, pharmacists have been placed in a unique position to review, document and co-chart medications with the prescriber.

Is PPMC a step towards pharmacist prescribing and advanced practice? Would it be a basis of pharmacist prescribing? How can we work towards an advanced practice pharmacist model?

Session sponsored by 

Fight with care – scientific guidelines and partnerships to improve access for patients with skin toxicities as a result of cancer care

Chair: Associate Professor Victoria Mar

Fight with Care is the new program from La Roche Posay working to highlight the importance of a holistic approach when treating oncology treatment side effects. We welcome you to join us for an evening with the scientific experts behind the campaign, discussion around the treatment guidelines and management of skin toxicities in oncology patients and discover the work we do, in partnership with the McGrath foundation, to drive better access for patients who experience skin toxicities as a result of their cancer therapy.

Skin toxicities

Fight with Care program launch incl. Onco-dermatology clinic at Princess Alexandra Hospital

Session sponsored by

 

Age is just a number: Optimising the care of older individuals with cancer

Co-Chair: Michael Krasovitsky

Co-Chair: Paul Viray

This breakfast session is designed to engage the audience in a facilitated discussion about the value of extending representation in multidisciplinary meetings to improve care for older patients with cancer. Case examples from breast and non-breast cancer patients will provide opinions from surgical, radiation oncology and medical oncology perspectives. Additional opinions will then be contributed from other perspectives to demonstrate the value of extending this discussion to include geriatrician, nursing/allied health/pharmacy, and consumer perspectives.

Session sponsored by 

Managing Brain Metastases in HER2-Positive mBC

Chair: Belinda Yeo

A multi-disciplinary panel of three leading Medical Oncologists, a Neurosurgeon, Radiation Oncologist and a Nurse Practitioner will discuss the challenges and various treatment strategies for the management of HER2+ mBC patients with CNS disease. They will explore real-world case studies from Australia and share their expert opinions and latest clinical data on supporting treatment decisions made.

Session sponsored by 

Considerations for treatment with KEYTRUDA (pembrolizumab) in patients with TNBC

Session sponsored by 

Metastatic breast cancer

9:00 AM Shom Goel

New drugs and approaches that have brought about progress abs# 62

9:20 AM Stephen Luen

Looking for genomic alterations in breast cancer: Should these be part of routine care? abs# 63

9:40 AM Kerry Patford

Dedicated metastatic breast care nurses – Providing expert clinical and supportive care to those with metastatic breast cancer abs# 64

9:55 AM Steven David

Oligometastatic breast cancer: Current status and future directions abs# 65

10:15 AM Panel discussion

Session sponsored by 

 

Tea break sponsored by 

 

End of life care

Chair: Sonia Fullerton

11:00 AM David Speakman

VAD and cancer care abs# 66

11:20 AM Barbara Hayes

How useful is advance care planning for informing consent and goals of care in Oncology? abs# 67

11:40 AM Aaron Wong

Opioid use in palliative care: Are we closer to personalised treatment using pharmacogenomics? abs# 68

12:00 PM Panel discussion

Breast reconstruction in 2023

Chair: Sophie Nightingale

11:00 AM Natalie Ngan

Implant reconstruction – Advances and controversies in implant-based reconstruction abs# 69

11:20 AM Gillian Farrell

Breast implant safety and the ABDR abs# 70

11:40 AM Cheng Hean Lo

Breast surgery and reconstruction in transgender people abs# 71

12:00 PM Victoria Gurvich

Breast reconstruction: A patient's perspective abs# 72

12:10 PM Panel discussion

Sexuality and sexual health

Chair: Lesley Stafford

11:00 AM Naveena Nekkalapudi

Consumer perspective – Challenging assumptions and norms abs# 73

11:20 AM Eliza Bailey

Using sex positivity as a framework abs# 74

11:35 AM Safeera Hussainy

Let's talk about sex, baby: communicating about the sexual side effects of anti-cancer therapies abs# 76

11:50 AM Wendy Vanselow

Sex life Matters: Informed consent in Cancer treatment abs# 75

12:05 PM Panel discussion

Best of the Best Oral Presentations – Basic and Translational Research

Chair: Geeta Sandhu

Discussant: Sabe Sabesan

11:00 AM Dilanka De Silva

Combined germline and somatic sequencing in breast cancer confirms the pathogenicity of the underlying germline mutation and identifies therapeutically vulnerable tumours. abs# 77

11:15 AM Ashish Banerjee

Differentiation of niraparib and olaparib brain penetration in a mouse brain metastatic tumour model abs# 78

11:30 AM Richard Rebello

Employing clinical whole-genome sequencing in the diagnostic work-up of cancer of unknown primary abs# 79

11:45 AM Wei Zhao

MRI-based radiomics model for preoperative prediction of lateral pelvic lymph node metastasis in locally advanced rectal cancer abs# 80

12:00 PM Xiaohe Zhou

Tumour cell-released autophagosomes (TRAPs) promote breast cancer lung metastasis by modulating neutrophil extracellular traps formation abs# 81

Best of the Best Oral Presentations – Gynaecological Cancer

Chair: Nicole Kinnane

Discussant: Michael Friedlander

11:00 AM Yoland C Antill

The impact of cause of mismatch repair deficiency and other molecular markers on clinical outcomes with the use of durvalumab in advanced endometrial cancer in the phase 2 PHAEDRA trial (ANZGOG1601). abs# 82

11:15 AM Amelia Hyatt

An ecological assessment of health system performance, universal health coverage and socio-cultural factors associated with progress towards cervical cancer elimination targets abs# 83

11:30 AM Grace L Rose

Exercise delivery is feasible, but recruitment is not for women following treatment for gynaecological: Preliminary findings from the enhancing treatment outcomes after gynaecological cancer (ACUMEN) study abs# 84

11:45 AM Scott C Walsberger

Empowering people with a cervix to own their cervical screening abs# 85

12:00 PM Kate Webber

The impact of real-time Patient Reported Outcome Measures (PROMs) on Emergency Department presentations in people with gynaecological cancer abs# 86

12:15 PM Aleesha Whitely

Impact of the COVID-19 pandemic on epithelial ovarian cancer diagnosis, management patterns and survival in Victoria: Insights from the National Gynae-Oncology Registry abs# 87

Session sponsored by 

 

Advancing Cancer Control: Strategies for Implementing the Australian Cancer Plan

1:50 PM Dorothy Keefe

Advancing cancer control: Strategies for implementing the Australian cancer plan abs# 141

Panellists:

Tanya Buchanan – CEO, Cancer Council Australia

Tom Calma AO – National Coordinator, Tackling Indigenous Smoking

Shelley Dolan – CEO, The Royal Melbourne Hospital

Lillian Leigh – Consumer

Paul Villanti – Movember

 

Tea break sponsored by 

 

Tricky cases in breast cancer – join the MDM

Chair: Belinda Yeo

Panellists:

Etienne Brain – Medical oncologist

Caroline Baker – Surgeon

Michael Chao – Radiation oncologist

Lesley Stafford – Clinical psychologist

Marissa Stevens – Nurse practitioner

Kate Stewart – Pathologist

Michelle White – Medical oncologist

Session sponsored by 

Genomics

Chair: Amy Davies

4:00 PM Geoffrey Lindeman

Universal germline testing for women with newly diagnosed breast cancer in a multidisciplinary setting – impact and benefit  abs# 88

4:20 PM Christine Muttiah

BRCA-P: Can denosumab prevent breast cancer in BRCA1 mutation carriers? abs# 89

4:40 PM Michelle Wilson

The role of germline and genomic testing in the management of gynae cancers abs# 90

5:00 PM  Jolyn Hersch

Ensuring ethical and flexible consent in cancer genomic research and clinical practice abs# 91

What are we doing to reduce risk?

Chairs: Andrew Murnane and Belinda Steer

4:00 PM Brigid Lynch

Estimating the number of cancers attributable to low physical activity in Australia abs# 92

4:20 PM Anna Boltong

Global supportive care initiatives: improving cancer outcomes through diet and exercise abs# 93

4:40 PM Darren Brenner

Using data to drive impact in cancer prevention abs# 94

5:00 PM Camille Short

Supporting health behaviour change at scale: what can we achieve with digital behaviour change interventions? abs# 95

5:20 PM Panel discussion

Best of the Best Oral Presentations – Clinical Research

Chair: Connie Diakos

Discussant: Christopher Steer

4:00 PM Kin Yin Chan

Prevalence of bowel and pelvic floor dysfunction after colorectal cancer surgery and primary cancer treatment abs# 96

4:15 PM Lara Edbrooke

Developing a Lung Cancer Rehabilitation core outcome set: An International Delphi Study (UNITE). abs# 98

4:30 PM Xinxin Hu

Comparing the utility of PLCOm2012 and the USPSTF2021 criteria in selecting high-risk individuals for lung cancer screening in the NSW cohort of the International Lung Screening Trial (ILST) abs# 99

4:45 PM Zev A Wainberg

NAPOLI-3: A randomised, open-label phase 3 study of NALIRIFOX versus nab-paclitaxel and gemcitabine in treatment-naïve patients with metastatic pancreatic ductal adenocarcinoma (mPDAC) abs# 101

Best of the Best Oral Presentations – Health Services II

Chair: Ian Olver

Discussant: Faye Coe

4:00 PM Prue Cormie

Exercise conversations: A mixed methods study explaining what people with cancer need from their cancer care team to facilitate adherence with exercise guidelines abs# 102

4:15 PM David Goldsbury

Out-of-pocket healthcare costs for people with and without cancer in NSW, Australia abs# 103

4:30 PM Katharina MD Merollini

Costs of palliative care for cancer patients in the public acute healthcare setting: Results from a Queensland population data linkage study (COS-Q) abs# 104

4:45 PM Brighid Scanlon

Equity across the cancer care continuum for culturally and linguistically diverse migrant populations living in Queensland, Australia: An exploratory sequential mixed methods study abs# 105

5:00 PM Ben Smith

Establishing a world-first evidence- and consensus-based clinical pathway for fear of cancer recurrence: Optimal on paper, but is it feasible in practice? abs# 106

5:15 PM Srinivas Teppala

Cost-effectiveness of germline BRCA testing in metastatic prostate cancer followed by cascade testing of first-degree relatives of mutation carriers. abs# 107

 

Antibody drug conjugates – riding the next wave

Antibody drug conjugates are a rapidly expanding class of treatments in oncology that fuse the specificity of a monoclonal antibody to improve the effectiveness of chemotherapy. As these develop as a new class in multiple therapy areas, those working in oncology need to understand how these modalities combine to best identify and support patients. This session will bring together experts across disease areas to cover the science, review recent data and discuss the impact on their own group of patients as well as their own experience to date. Join this interactive session to learn from other experts in the field and have your questions answered on this emerging field.

Chair: Dr Melissa Moore

Session sponsored by

Dynamic Duo: unlocking the potential of Lenvatinib and Pembrolizumab in endometrial cancer care

Chair: Yoland Antill

Until recently, standard of care treatment options for advanced endometrial carcinoma (EC) have been limited to cytotoxic treatment regimens. This session aims to provide an overview of the current EC clinical trial landscape and will delve into a real-world clinical case study of patient management with the recent PBS reimbursed combination of lenvatinib and pembrolizumab.

Lenvima (lenvatinib) PBS Information: Authority required (STREAMLINED). Lenvima in combination with Keytruda (pembrolizumab) is PBS listed for certain patients with advanced, metastatic or recurrent EC. Refer to PBS schedule for full authority information.

Please review full Lenvima Product Information before prescribing, available from www.eisai.com.au/PI

Please review full Keytruda Product Information before prescribing, available from www.msdinfo.com.au/keytrudapi

Session sponsored by 

Today's Education to Support Tomorrow's Clinical Trial World

Chair: Mark Buzza

The landscape of clinical research is constantly evolving, and the introduction of novel trial methodologies disrupt the traditional clinical trial landscape. Updates to legislation and new processes bring further change, and, while they elevate the sector, support and guidance available for the research workforce is often limited. Teletrials and Registry-based Clinical Trials are both innovative trial designs that show great promise in answering research questions in real-world populations, with particular advantages for rural and regional groups, but both have yet to have their potential fully realised, in part due to clinician apprehension and awareness. Meanwhile, the introduction of the National Clinical Trial Governance Framework (NCTGF) will significantly impact both clinical trial units and research and governance offices and their ability to capture and report metrics. Finally, researchers stepping into business management roles were found to lack available fit-for-purpose and tailored support. Newly released education including toolkits, online courses and live resources have been developed to assist the research workforce in these areas, delivered as part of a broader overview of context with practical take away lessons in these areas.

Session sponsored by 

Building a roadmap to address the financial toxicity of cancer in Australia

Chair: Megan Varlow

7:15 AM Megan Varlow

Financial toxicity: An unacceptable side effect of cancer in Australia abs# 108

7:25 AM Louisa Gordon

Tackling financial toxicity, the views of health professionals abs# 109

7:40 AM Jordana McLoone

Challenges and solutions to cancer-related financial toxicity according to Australian health professionals: Qualitative results from a national survey abs# 110

7:55 AM Raymond Chan

A national roadmap to addressing financial toxicity abs# 111

Session sponsored by 

 

Decarbonising oncology in Australia

Chair: Brigid Lynch

9:00 AM Stefanie Carino

Global Green and Healthy Hospitals OR Roadmap for healthcare decarbonisation abs# 112

9:15 AM Angie Bone

Driving systems change for sustainable healthcare: buy-in from the ground up abs# 113

9:30 AM Forbes McGain

Clinical leadership to reduce the environmental impact of health care. abs# 114

9:45 AM Felicity Wright

Decarbonising pediatric cancer care: case-study from the Kids Cancer Centre abs# 115

10:00 AM Panel discussion

Tea break sponsored by

 

Hot topics in gynae cancer

Chair: Michael Friedlander

11:00 AM Michelle Wilson

The current and future role of PARP inhibitors in ovarian cancer abs# 116

11:15 AM George Au-Yeung

What's new in medical oncology treatments for endometrial cancer? abs# 117

11:30 AM Simon Hyde

What's new in surgical therapies for gynae cancers? abs# 118

11:45 AM Rachel Delahunty

Is there a role for ctDNA in the management of gynae cancers? abs# 119

12:00 PM Panel discussion

Session sponsored by

Living well with and beyond cancer

Chair: Nicole Kinnane and Kathryn Bell

11:00 AM Jodie Lydeker

Finding the new normal abs# 120

11:15 AM Paul Glare

Managing pain and related symptoms in cancer survivors. abs# 121

11:30 AM Elizabeth J Pearson

Cancer fatigue – Tackling a hidden, disabling symptom in routine cancer care abs# 122

11:45 AM Joshua Wiley

Scalable interventions for sleep after cancer abs# 123

12:00 PM Panel discussion

Session sponsored by

Hot topics in local therapies – Is less more?

Chair: Sophie Nightingale

11:00 AM David Speakman

The Axilla – decreasing surgery, decreasing lymphoedema abs# 124

11:22 AM Fiona Hegi-Johnson

Decreasing breast radiotherapy abs# 125

11:44 AM Satomi Koide

Partial breast reconstruction abs# 126

12:06 PM Joshua Lin

Less travel, more options – breast surgery in regional Victoria. abs# 127

Session sponsored by

PRIMCAT: A consumer engaged modelling approach to determine the health economic impact of cancer treatments shaping the future of cancer care in Australia

Chair: Karen Trapani

11:00 AM Karen Trapani

Consumer partnership impacting Australian health technology assessment policy abs# 128

11:15 AM Fanny Franchini

Treatment patterns in Victoria across three cancers: An in-depth analysis abs# 129

11:30 AM Ou Yang

Examining factors affecting cancer treatment costs abs# 130

11:45 AM Benjamin Daniels

Uptake of recently PBS-listed cancer medicines abs# 131

12:00 PM Fanny Franchini

Forecasting the future impact of novel therapies on cancer treatment in Australia abs# 132

Successes and challenges of embedding digital health programs for people living with cancer in diverse healthcare settings

Chairs: Christina Signorelli and Ursula Sansom-Daly

11:00 AM Christina Signorelli

Challenges and successes of implementing the distance-delivered ‘Engage’ survivorship program for childhood cancer survivors in clinical practice abs# 133

11:15 AM Lisa Beatty

Scaling up and out with finding my way! abs# 134

11:30 AM Natalie Winter

The strategies employed to recruit for MindOnLine – A 9 week online mindfulness program for people who have completed treatment for bowel, breast or prostate cancer abs# 135

11:45 AM Ursula Sansom-Daly

Online peer support for young cancer survivors, and their parents, in community settings: Learnings from the Recapture Life and Cascade implementation trials abs# 136

12:00 PM Eden G Robertson

Redkite and the Behavioural Sciences Unit, Kids Cancer Centre: The power of partnership to create national impact for children with cancer and their families abs# 137

Lunch sponsored by

 

COSA/UICC Plenary: The cost to cure

Chairs: Jeff Dunn and Grant McArthur

1:30 PM Sherene Loi

Exploring the evidence for immunotherapy in breast cancer abs# 138

1:50 PM Cary Adams

Access to Oncology Medicines (ATOM) abs# 139

2:10 PM Michael Jefford

Survivorship-reconsidering clinical care, policy and research priorities for the modern era abs# 140

2:30 PM Panel discussion including Dr Donna Milne

COSA Presidential Lecture – It's all about cancer. Or is it?

Chair: Dion Forstner

Presenter: Bogda Koczwara AM

Close

Chair: Dion Forstner